VJHemOnc Podcast cover image

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances

VJHemOnc Podcast

CHAPTER

Advancements in Targeted Therapies and Imaging for Myeloma

This chapter explores the exciting progress in targeted therapies for myeloma, including the use of vanetta clacks to target the BCL2 protein and the potential of next-generation molecules like MCL1. It also discusses the importance of intelligent drug combinations and the development of new imaging technologies for improved disease monitoring.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner